Advances in follicular lymphoma

被引:13
作者
Archuleta, TD [1 ]
Armitage, JO [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Internal Med, Hematol Oncol Sect, Omaha, NE 68198 USA
关键词
D O I
10.1053/j.seminoncol.2004.02.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:66 / 71
页数:6
相关论文
共 46 条
[41]   Long-term results with radiotherapy for stage I-II follicular lymphomas [J].
Wilder, RB ;
Jones, D ;
Tucker, SL ;
Fuller, LM ;
Ha, CS ;
McLaughlin, P ;
Hess, MA ;
Cabanillas, F ;
Cox, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (05) :1219-1227
[42]   Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma [J].
Witzig, TE ;
Flinn, IW ;
Gordon, LI ;
Emmanouilides, C ;
Czuczman, MS ;
Saleh, MN ;
Cripe, L ;
Wiseman, G ;
Olejnik, T ;
Multani, PS ;
White, CA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3262-3269
[43]   Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma [J].
Witzig, TE ;
Gordon, LI ;
Cabanillas, F ;
Czuczman, MS ;
Emmanouilides, C ;
Joyce, R ;
Pohlman, BL ;
Bartlett, NL ;
Wiseman, GA ;
Padre, N ;
Grillo-López, AJ ;
Multani, P ;
White, CA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2453-2463
[44]  
YOSSI C, 2003, TRENDS HEMATOL ONCOL, V88, P811
[45]  
ZINZANI PL, 1995, EUR J HAEMATOL, V55, P262
[46]   FLUDARABINE - AN ACTIVE AGENT IN THE TREATMENT OF PREVIOUSLY-TREATED AND UNTREATED LOW-GRADE NON-HODGKINS-LYMPHOMA [J].
ZINZANI, PL ;
LAURIA, F ;
RONDELLI, D ;
BENFENATI, D ;
RASPADORI, D ;
BOCCHIA, M ;
BENDANDI, M ;
GOZZETTI, A ;
ZAJA, F ;
FANIN, R ;
RUSSO, D ;
GALIENI, P ;
TURA, S .
ANNALS OF ONCOLOGY, 1993, 4 (07) :575-578